For patients pursuing integrative wellness protocols, DSIP may be considered alongside other evidence-informed approaches such as NAD+ therapy, peptide support, and IV nutritional therapy
In August 2023, a lawsuit was filed against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro, respectively
Gut 50, suppl
This insight helps identify whether you'll respond optimally to semaglutide or might benefit from tirzepatide or dual-compound therapy for better personalized outcomes
The Wu administration will soon limit coverage of GLP-1 weight loss drugs and other medications for city employees and retirees, a move officials say will save Boston nearly $11 million amid an ongoing budget crunch, Wus office said Wednesday
Prevalence of normal Coronary Arteries by Coronary Computed Tomography Angiography (CCTA) in Patients with Type 2 Diabetes Mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) Trial